Developmental neuropathology in DNT-studies-A sensitive tool for the detection and characterization of developmental neurotoxicants

Reproductive Toxicology

Volumn 22, Issue 2, 2006, Pages 196-213

  Kaufmann, Wolfgang ^a   Gröters, Sibylle ^a  

^a BASF SE   (Germany)

Author keywords

Brain morphometry; Developmental neuropathology; DNT studies; Heterotopiae; Practical approaches; Qualitative analysis; Quantitative analysis

Indexed keywords

NEUROTOXIN;

BRAIN REGION; BRAIN TISSUE; BRAIN WEIGHT; DEVELOPMENTAL DISORDER; HISTOLOGY; HISTOPATHOLOGY; HUMAN; MEDICAL LITERATURE; MORPHOLOGY; MORPHOMETRICS; NERVE CELL DIFFERENTIATION; NERVOUS TISSUE; NEUROPATHOLOGY; NEUROTOXICITY; NONHUMAN; PRACTICE GUIDELINE; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; REPRODUCTIVE TOXICITY; REVIEW;

ANIMALS; BRAIN; FEMALE; HAZARDOUS SUBSTANCES; NERVOUS SYSTEM DISEASES; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; TOXICITY TESTS;

EID: 33745592511     PISSN: 08906238     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.reprotox.2006.04.021     Document Type: Review

References (102)

1. EPA, 1998a. Health Effects Test Guidelines OPPTS 870.6300, Devlopmental Neurotoxicity Study. http://www.epa.gov/epahome/research.htm.
2. OECD, 1999. Revised Draft Guideline 426: Developmental Neurotoxicity Study. http://www.oecd.org/ehs/test/health.htm.
3. Friede R.L. Dysplasias of cerebral cortex. In: Friede R.L. (Ed). Developmental Neuropathology (1989), Springer-Verlag, Berlin 330-346
4. EPA, 1998b. Health Effects Test Guidelines OPPTS 870.6200 Neurotoxicity Screening Battery. http://www.epa.gov/epahome/research.htm.
5. Garman R.H., Fix A.S., Jortner B.S., Jensen K.F., Hardisty J.F., Claudio L., et al. Methods to identify and characterize developmental neurotoxicity for human health risk assessment II: neuropathology. Environ Health Perspect 109 Suppl 1 (2001) 93-100
6. Crofton K.M., Makris S.L., Sette W.F., Mendez E., and Raffaele K.C. A qualitative retrospective analysis of positive control data in developmental neurotoxicity studies. Neurotox Teratol 26 (2004) 345-352
7. Duffell S.J., Soames A.R., and Gunby S. Morphometric analysis of the developing rat brain. Toxicol Pathol 28 (2000) 157-163
8. de Groot D.M., Hartgring S., van de Horst L., et al. 2D and 3D assessment of neuropathology in rat brain after prenatal exposure to methylazoxymethanol, a model for developmental neurotoxicity. Reprod Toxicol 20 (2005) 417-432
9. Cory-Slechta D.A., Thiruchelvam M., Barlow B.K., and Richfield E.K. Developmental pesticide models of the Parkinson disease phenotype. Environ Health Perspect 113 (2005) 1263-1270
10. Barlow B.K., Richfield E.K., Cory-Slechta D.A., and Thiruchelvam M. A fetal risk factor for Parkinson's disease. Dev Neurosci 26 (2004) 11-23
11. Himwich W.A. Problems in interpreting neurochemical changes occuring in developing and aging animals. In: Ford D.H. (Ed). Neurobiological Aspects of Maturation and Aging Progress in Brain Research 40 (1973), Elsevier press, Amsterdam 13
12. Kaufmann W. Developmental Neurotoxicity. In: Krinke G.J. (Ed). The Laboratory Rat (2000), Academic Press, San Diego 227-250
13. Davison A.N., and Dobbing J. The developing brain. In: Davison A., and Dobbing J. (Eds). Applied Neurochemistry (1968), Blackwell, Oxford
14. Krinke GJ, Personal communication. 2002.
15. Fix A.S., and Garman R.H. Practical aspects of neuropathology: a technical guide for working with the nervous system. Toxicol Pathol 28 (2000) 122-131
16. Bolon B., Garman R., Jensen K., Krinke G., and Stuart B. A 'Best Practices' Approach to Neuropathology Assessment in Developmental Neurotoxicity Testing-for Today. Toxicol Pathol 34 (2006) 296-313
17. Fix A.S., Ross J.F., Stitzel S.R., and Switzer R.C. Integrated evaluation of central nervous system lesions: stains for neurons, astrocytes, and microglia reveal the spatial and temporal features of MK-801-induced neuronal necrosis in the rat cerebral cortex. Toxicol Pathol 24 (1996) 291-304
18. De Olmos J.S., Beltramino C.A., and de Olmos de Lorenzo S. Use of an amino-cupric-silver technique for the detection of early and semiacute neuronal degeneration caused by neurotoxicants, hypoxia, and physical trauma. Neurotoxicol Teratol 16 (1994) 545-561
19. Barone Jr. S., Das K.P., Lassiter T.L., and White L.D. Vulnerable processes of nervous system development: a review of markers and methods. Neurotoxicology 21 (2000) 15-36
20. Krinke G.J., Classen W., Vidotto N., Suter E., and Wurmlin C.H. Detecting necrotic neurons with fluoro-jade stain. Exp Toxicol Pathol 53 (2001) 365-372
21. Olney J.W., Farber N.B., Wozniak D.F., Jevtovic-Todorovic V., and Ikonomidou C. Environmental agents that have the potential to trigger massive apoptotic neurodegeneration in the developing brain. Environ Health Perspect 108 Suppl. 3 (2000) 383-388
22. Olney J.W. New insights and new issues in developmental neurotoxicology. Neurotoxicology 23 (2002) 659-668
23. Schmued L.C., Stowers C.C., Scallet A.C., Xu L., and Fluoro-Jade C. results in ultra high resolution and contrast labeling of degenerating neurons. Brain Res 1035 (2005) 24-31
24. Schmued L.C., Hopkins K.J., and Fluoro-Jade B. a high affinity fluorescent marker for the localization of neuronal degeneration. Brain Res 874 (2000) 123-130
25. Schmued L., and Slikker Jr. W. Black-Gold: a simple, high-resolution histochemical label for normal and pathological myelin in brain tissue sections. Brain Res 837 (1999) 289-297
26. Streit W.J. An improved staining method for rat microglial cells using the lectin from Griffonia simplicifolia (GSA I-B4). J Histochem Cytochem 38 (1990) 1683-1686
27. Kaur C., Ling E.A., and Wong W.C. Lectin labelling of amoeboid microglial cells in the brain of postnatal rats. J Anat 173 (1990) 151-160
28. Schlote W. In: Doerr W., and Seifert G. (Eds). Spezielle pathologische Anatomie. Pathologie des Nervensystems II (1983), Springer-Verlag, Berlin 2-172
29. Denk H., Künzle H., Plenk Jr. H., Rüschoff J., and Sellner W. In: Böck P. (Ed). Mikroskopische Technik/Romeis (1989), Urban und Schwarzenberg, München
30. Carratu M.R., Cagiano R., De Salvia M.A., Trabace L., and Cuomo V. Developmental neurotoxicity of carbon monoxide. Arch Toxicol Suppl 17 (1995) 295-301
31. Bayer S.A., Altman J., Russo R.J., and Zhang X. Timetables of neurogenesis in the human brain based on experimentally determined patterns in the rat. Neurotoxicology 14 (1993) 83-144
32. Collier P.A., and Ashwell K.W. Distribution of neuronal heterotopias following prenatal exposure to methylazoxymethanol. Neurotoxicol Teratol 15 (1993) 439-444
33. Norman M.G. Bilateral encephaloclastic lesions in a 26 week gestation fetus: effect on neuroblast migration. Can J Neurol Sci 7 (1980) 191-194
34. Streissguth A.P., Landesman-Dwyer S., Martin J.C., and Smith D.W. Teratogenic effects of alcohol in humans and laboratoty animals. Science 209 (1980) 353-361
35. Rakic P. Cell migration and neuronal ectopias in the brain. Birth Defects Orig Artic Ser 11 (1975) 95-129
36. Spatz M., and Laqueur G.L. Transplacental chemical induction of microencephaly in two strains of rat 1. Proc Soc Exp Biol Med 129 (1968) 705-710
37. Singh S.C. Ectopic neurones in the hippocampus of the postnatal rat exposed to methylazoxymethanol during foetal development. Acta Neuropathol 40 (1977) 111-116
38. Hallas B.H., and Das G.P. An aberrant nucleus in the telencephalon following administration of ENU during neuroembryogenesis. Teratology 19 (1979) 159-164
39. Paredes M., Pleasure S.J., and Baraban S.C. Embryonic and early postnatal abnormalities contributing to the development of hippocampal malformations in a rodent model of dysplasia. J Comp Neurol 495 (2006) 133-148
40. Yamazaki H., Sekiguchi M., Takamatsu M., Tanabe Y., and Nakanishi S. Distinct ontogenic and regional expressions of newly identified Cajal-Retzius cell-specific genes during neocorticogenesis. Proc Natl Acad Sci 101 (2004) 14509-14514
41. Gabel L.A., and LoTurco J.J. Electrophysiological and morphological characterization of neurons within neocortical ectopias. J Neurophysiol 85 (2001) 495-505
42. Zhu W.J., and Roper S.N. Reduced inhibition in an animal model of cortical dysplasia. J Neurosci 20 (2000) 8925-8931
43. Chen H.X., and Roper S.N. Reduction of spontaneous inhibitory synaptic activity in experimental heterotopic gray matter. J Neurophysiol 89 (2003) 150-158
44. Roper S.N., Eisenschenk S., and King M.A. Reduced density of parvalbumin- and calbindin D28-immunoreactive neurons in experimental cortical dysplasia. Epilepsy Res 37 (1999) 63-71
45. Schmechel D.E., and Rakic P. A Golgi study of radial glial cells in developing monkey telencephalon: morphogenesis and transformation into astrocytes. Anat Embryol 156 (1979) 115-152
46. Bliss T.V., and Collingridge G.L. A synaptic model of memory: long-term potentiation in the hippocampus. Nature 361 (1993) 31-39
47. Peters O., Redecker C., Hagemann G., Bruehl C., Luhmann H.J., and Witte O.W. Impaired synaptic plasticity in the surround of perinatally acquired dysplasia in rat cerebral cortex. Cereb Cortex 14 (2004) 1081-1087
48. Rodier P.M., and Gramann W.J. Morphologic effects of interference with cell proliferation in the early fetal period. Neurobehav Toxicol 1 (1979) 129-135
49. York R.G., Barnett J., Girard M.F., Mattie D.R., Bekkedal M.V., Garman R.H., et al. Refining the effects observed in a developmental neurobehavioral study of ammonium perchlorate administered orally in drinking water to rats II. Behavioral Neurodevelopmental effects. Int J Toxicol 24 (2005) 451-467
50. Bové J., Prou D., Perier C., and Przedborski S. Toxin-induced models of Parkinson's disease. NeuroRx 2 (2005) 484-494
51. Johnston M.V., and Coyle J.T. Histological and neurochemical effects of fetal treatment with methylazoxymethanol on rat neocortex in adulthood. Brain Res 170 (1979) 135-155
52. Fischer M.H., Welker C., and Waisman H.A. Generalized growth retardation in rats induced by prenatal exposure to methylazoxymethanol acetate. Teratology 5 (1972) 223-232
53. Ferguson S.A., Racey F.D., Paule M.G., and Holson R.R. Behavioral effects of methylazoxymethanol-induced microencephaly. Behav Neurosci 107 (1993) 1067-1076
54. Goldey E.S., O'Callaghan J.P., Stanton M.E., Barone Jr. S., and Crofton K.M. Developmental neurotoxicity: evaluation of testing procedures with methylazoxymethanol and methylmercury. Fundam Appl Toxicol 23 (1994) 447-464
55. Kabat K., Buterbaugh G.G., and Eccles C.U. Methylazoxymethanol as a developmental model of neurotoxicity. Neurobehav Toxicol Teratol 7 (1985) 519-525
56. Ferguson S.A., Paule M.G., and Holson R.R. Functional effects of methylazoxymethanol-induced cerebellar hypoplasia in rats. Neurotoxicol Teratol 18 (1996) 529-537
57. Hirono I., Shibuya C., and Hayashi K. Induction of a cerebellar disorder with cycasin in newborn mice and hamsters. Proc Soc Exp Biol Med 131 (1969) 593-599
58. Colacitti C., Sancini G., DeBiasi S., et al. Prenatal methylazoxymethanol treatment in rats produces brain abnormalities with morphological similarities to human developmental brain dysgeneses. J Neuropathol Exp Neurol 58 (1999) 92-106
59. Colacitti C., Sancini G., Franceschetti S., et al. Altered connections between neocortical and heterotopic areas in methylazoxymethanol-treated rat. Epilepsy Res 32 (1998) 49-62
60. Fiore M., Korf J., Antonelli A., Talamini L., and Aloe L. Long-lasting effects of prenatal MAM treatment on water maze performance in rats: associations with altered brain development and neurotrophin levels. Neurotoxicol Teratol 24 (2002) 179-191
61. Hartkop T.H., and Jones M.Z. Methylazoxymethanol-induced aberrant Purkinje cell dendritic development. J Neuropathol Exp Neurol 36 (1977) 519-532
62. Baraban S.C., Wenzel H.J., Hochman D.W., and Schwartzkroin P.A. Characterization of heterotopic cell clusters in the hippocampus of rats exposed to methylazoxymethanol in utero. Epilepsy Res 39 (2000) 87-102
63. Calcagnotto M.E., Paredes M.F., and Baraban S.C. Heterotopic neurons with altered inhibitory synaptic function in an animal model of malformation-associated epilepsy. J Neurosci 22 (2002) 7596-7605
64. Oyanagi K., Yoshida Y., and Ikuta F. Cytoarchitectonic investigation of the rat spinal cord following ethylnitrosourea administration at different developmental stages. Virchows Archiv A Pathol Anat Histopathol 412 (1988) 215-224
65. Dalgaard M., Hossaini A., Hougaard K.S., Haas U., and Ladefoged O. Developmental toxicity of toluene in male rats: effects on semen quality, testis morphology, and apoptotic neurodegeneration. Arch Toxicol 75 (2001) 103-109
66. Volk B. Delayed cerebellar histogenesis in "embryofetal alcohol syndrome" Light microscopic study of the rat cerebellum. (Verzögerte Kleinhirnentwicklung im Rahmen des "embryofetalen Alkoholsyndroms"). Acta Neuropathol 39 (1977) 157-163
67. Komatsu S., Sakata-Haga H., Sawada K., Hisano S., and Fukui Y. Prenatal exposure to ethanol induces leptomeningeal heterotopia in the cerebral cortex of the rat fetus. Acta Neuropathol 101 (2001) 22-26
68. York R.G., Barnett Jr. J., Brown W.R., Garmann R.H., Mattie D.R., and Dodd D. A rat neurodevelopmental evaluation of offspring, including evaluation of adult and neonatal thyroid, from mothers treated with ammonium perchlorate in drinking water. Int J Toxicol 23 (2004) 191-214
69. Marret S., Gressens P., and Evrard P. Arrest of neuronal migration by excitatory amino acids in hamster developing brain. Proc Natl Acad Sci 93 (1996) 15463-15468
70. Gressens P., Arquié C., Hill J.M., Marret S., Sahir N., Robberecht P., et al. VIP and PACAP 38 modulate ibotenate-induced neuronal heterotopias in the newborn hamster neocortex. J Neuropathol Exp Neurol 59 (2000) 1051-1062
71. Zieher L.M., and Jaim-Etcheverry G. Regional differences in the long-term effect of neonatal 6-hydroxydopa treatment on the rat brain noradrenaline. Brain Res 60 (1973) 199-207
72. Rice D.C. Delayed neurotoxicity in monkeys exposed developmentally to methylmercury. Neurotoxicology 10 (1989) 645-650
73. Kutscher C.L., Sembrat M., Kutscher C.S., and Kutscher N.L. Effects of the high methylmercury dose used in the collaborative behavioral teratology study on brain anatomy. Neurobehav Toxicol Teratol 7 (1985) 775-777
74. Barone Jr. S., Haykal-Coates N., Parran D.K., and Tilson H.A. Gestational exposure to methylmercury alters the developmental pattern of trk-like immunoreactivity in the rat brain and results in cortical dysmorphology. Brain Res Dev Brain Res 109 (1998) 13-31
75. Roegge C.S., Morris J.R., Villareal S., et al. Purkinje cell and cerebellar effects following developmental exposure to PCBs and/or MeHg. Neurotoxicol Teratol 28 (2006) 74-85
76. Reuhl K.R. Tellurium poisoning, rat. In: Jones T.C., Mohr U., and Hunt R.D. (Eds). Nervous System, Monographs on Pathology of Laboratory Animals Sponsored by the International Life Science Institute (1988), Springer-Verlag, Berlin 101-103
77. Duckett S. The morphology of tellurium-induced hydrocephalus. Exp Neurol 31 (1971) 1-16
78. Garro F., and Pentschew A. Neonatal hydrocephalus in the offspring of rats fed during pregnancy non-toxic amounts of tellurium. Arch Psychiatr Nervenkr 206 (1964) 272-280
79. Duckett S., and White R. Cerebral lipofuscinosis induced with tellurium: electron dispersive X-ray spectrophotometry analysis. Brain Res 73 (1974) 205-214
80. Reuhl K.R. Cadmium poisoning, rat. In: Jones T.C., Mohr U., and Hunt R.D. (Eds). Nervous System, Monographs on Pathology of Laboratory Animals Sponsored by the International Life Science Institute (1988), Springer-Verlag, Berlin 104-107
81. Gabbiani G., Baic D., and Deziel C. Toxicity of cadmium for the central nervous system. Exp Neurol 18 (1967) 154-160
82. Gabbiani G., Gregory A., and Baic D. Cadmium-induced selective lesions of sensory ganglia. J Neuropathol Exp Neurol 26 (1967) 498-506
83. Aikawa H., and Suzuki K. Neurotoxic effects of 6-aminonicotinamide, mouse. In: Jones T.C., Mohr U., and Hunt R.D. (Eds). Nervous System, Monographs on Pathology of Laboratory Animals Sponsored by the International Life Science Institute (1988), Springer Verlag, Berlin 53-57
84. Aikawa H., Suzuki K., Ito N., Iwasaki Y., and Nonaka I. 6-Aminonicotinamide-induced hydrocephalus in suckling mice. J Neuropathol Exp Neurol 43 (1984) 511-521
85. Aikawa H., Kobayashi S., and Suzuki K. Aqueductal lesions in 6-aminonicotinamide-treated suckling mice. Acta Neuropathol (Berl) 71 (1986) 243-250
86. Patsalos P.N., and Wiggins R.C. Brain maturation following administration of phenobarbital, phenytoin, and sodium valproate to developing rats or to their dams: effects on synthesis of brain myelin and other subcellular membrane proteins. J Neurochem 39 (1982) 915-923
87. Michaelson I.A. Effects of inorganic lead on RNA DNA and protein content in the developing neonatal rat brain. Toxicol Appl Pharmacol 26 (1973) 539-548
88. Nieminen L., Bjondahl K., and Mottonen M. Effect of hexachlorophene on the rat brain during ontogenesis. Food Cosmet Toxicol 11 (1973) 635-639
89. Suzuki K., Zagoren J.C., Gonates J., and Suzuki K. Ultrastructural study of neuronal cytoplasmic inclusions produced by hypocholesterolemic drug AY 9944. Acta Neuropathol (Berl) 26 (1973) 185-197
90. Pelton E.W., Grindeland R.E., Young E., and Bass N.H. Effects of immunologically induced growth hormone deficiency on myelinogenesis in developing rat cerebrum. Neurology 27 (1977) 282-288
91. Alleva F.R., and Balazs T. Age-dependent sensitivity of the rat to neurotoxic effects of streptomycin. Toxicol Lett 6 (1980) 385-389
92. Takagishi Y., and Yamamura H. The critical period of Purkinje cell degeneration and cerebellar hypoplasia due to bilirubin. Acta Neuropathol (Berl) 75 (1987) 41-45
93. Rosselli-Austin L., and Yanai J. Neuromorphological changes in mouse olfactory bulb after neonatal exposure to phenobarbital. Neurotoxicol Teratol 11 (1989) 227-230
94. Burri R., Matthieu J.M., Vandevelde M., Lazeyras F., Posse S., and Herschkowitz N. Brain damage and recovery in hyperphenylalaninemic rats. Dev Neurosci 12 (1990) 116-125
95. Maurissen J.P.J., Hoberman A.M., Garman R.H., and Hanley Jr. T.R. Lack of selective developmental neurotoxicity in rat pups from dams treated by gavage with chlorpyrifos. Toxicol Sci 57 (2000) 250-263
96. Whitney K.D., Seidler F.J., and Slotkin T.A. Developmental neurotoxicity of chlorpyrifos: cellular mechanisms. Toxicol Appl Pharmacol 134 (1995) 53-62
97. Dam K., Garcia S.J., Seidler F.J., and Slotkin T.A. Neonatal chlorpyrifos exposure alters synaptic development and neuronal activity in cholinergic and catecholaminergic pathways. Brain Res Dev Brain Res 116 (1999) 9-20
98. Thiruchelvam M., Richfield E.K., Goodman B.M., Baggs R.B., and Cory-Slechta D.A. Developmental exposure to the pesticides paraquat and maneb and the Parkinson's disease phenotype. Neurotoxicology 23 (2002) 621-633
99. Nishida A., Kobayashi T., and Ariyuki F. Developmental toxicity of concanavalin A in rats: association with restricted migration of neural crest cells. Food Chem Toxicol 34 (1996) 701-708
100. Saporta S. Loss of spinothalamic tract neurons following neonatal treatment of rats with the neurotoxin capsaicin. Somatosens Res 4 (1986) 153-173
101. Baraban S.C., Wenzel H.J., Castro P.A., and Schwartzkroin P.A. Hippocampal dysplasia in rats exposed to cocaine in utero. Brain Res Dev Brain Res 117 (1999) 213-217
102. Ogawa T., Kuwagata M., Muneoka K.T., and Shioda S. Neuropathological examination of fetal rat brain in the 5-bromo-2′-deoxyuridine-induced neurodevelopmental disorder model. Congenit Anom (Kyoto) 45 (2005) 14-20